G. Geroulakos et al., USE OF THE SPLENIC AND HEPATIC-ARTERY FOR RENAL REVASCULARIZATION IN PATIENTS WITH ATHEROSCLEROTIC RENAL-ARTERY DISEASE, Annals of vascular surgery, 11(1), 1997, pp. 85-89
Citations number
16
Categorie Soggetti
Peripheal Vascular Diseas","Cardiac & Cardiovascular System
Hepatorenal and splenorenal bypasses are gaining an increased populari
ty as an alternative to renal artery endarterectomy and aortorenal byp
ass in selected patients. However, there are few reports of the long-t
erm results of this procedure. The purpose of this study was to assess
the performance of the hepatic and splenic arterial sources in patien
ts with atherosclerotic renal artery disease. We reviewed our 7-year e
xperience between 1988-1995. A total of 146 operative renal artery rec
onstructions were performed, including 45 hepatorenal and/or splenoren
al by-pass in 38 patients, (19 male, 19 female, mean age 62 +/- 12 yea
rs) for treatment of renovascular hypertension, renal preservation or
both. The mean preoperative creatinine was 2.95 mg/dl (2.11-3.47, 95%
confidence limits). The average number of antihypertensive medications
was 2.63. There was one postoperative death from myocardial infarctio
n and two cases of early graft thrombosis, one of which was treated by
thrombectomy reestablishing patency. In two patients with persistent
hypertension selective angiography demonstrated high-grade anastomotic
stenoses which were successfully dilated by balloon angioplasty. The
postoperative mean creatinine decreased to 2.54 mg/dl (1.82-3.27, 95%
confidence limits), (p = 0.17) and the average number of antihypertens
ive medications decreased to 1.9 (p = 0.001). During the median follow
-up of 33 months, 10 patients died, mainly from cardiac causes. Our ex
perience indicates that the splenic and hepatic arteries provide usefu
l alternatives to renal revascularization in selected circumstances wi
th an acceptable rate of perioperative mortality and morbidity. The ex
pected long-term survival in this group of patients is low.